$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Laparoscopic hepatectomy is widely utilized for the treatment of liver diseases. Laparoscopic resection of liver tumors is generally performed using a conventional surgical approach, with the primary aim of precisely dissecting the portal pedicle. However, accessing the pedicle via the hepatic hilum often necessitates a relatively deep intrahepatic dissection, which increases the risk of losing anatomical orientation and inadvertently injuring adjacent pedicles1.
In HCC, tumor recurrence remains a leading cause of patient mortality, and anatomical resection (AR) combined with a wide resection margin (RM) has been associated with improved prognosis compared with non-AR or a narrow RM after hepatectomy2,3. While a larger surgical margin may help prevent early recurrence of HCC, excessively wide margins can compromise the remaining liver parenchyma and lead to post-resection liver failure4. First described by Makuuchi et al. in 1985, anatomical resection involves removing the tumor along with the liver segment or subsegment that contains the tumor-bearing portal tributaries, as well as a major branch of the portal vein and hepatic artery5. In contrast, nonanatomic resection is a less extensive procedure that removes the lesion without regard to the liver's anatomical segments or lobar structure6. Thus, a novel strategy is needed to solve those clinical problems.
In 1802, Laennec first described a membrane distinct from the serosa, later termed Laennec’s capsule7. Previous study reported that Laennec’s capsule envelops the entire liver parenchyma independently of intrahepatic vessels and proposed its potential use as a basis for liver surgical anatomy8,9. The Laennec's capsule approach has recently gained widespread use in liver surgery. This membrane facilitates perihepatic dissection, hepatic pedicle isolation, exposure of the hepatic veins, and anatomical hepatectomy. Our previous study demonstrated that Laennec’s capsule can serve as an anatomical landmark for isolating the Glissonean pedicle and hepatic vein10. The application of the indocyanine green fluorescence (ICG) approach and the Glissonean approach in hepatectomy has shown its advantages11. The clinical application of ICG has enabled the development of fluorescence laparoscopes, which help visualize tumor boundaries. In liver resection, ICG can be used in two ways: positive staining and negative staining. Positive staining causes the target tissue to fluoresce, clearly outlining the anatomical boundaries of the tumor-bearing segment and supporting precise resection. Negative staining causes the non-target liver segments to fluoresce, while the target segment remains unstained and appears dark12. This strategy improves the removal of small residual tumor foci on the transection surface.
Given the development of various surgical methods, the combination of Lannec’s capsule and negative ICG staining has yet to be standardized due to the lack of supporting data. It offers significant advantages when the tumor is confined to a single hepatic segment. Thus, this study aims to demonstrate the technical feasibility of the fluorescence-guided laparoscopic regional anatomical combined subsegmental liver resection through the Laennec approach. This study describes the methodology in detail and reviews our findings to date.